RIGHI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.614
EU - Europa 1.903
AS - Asia 893
AF - Africa 159
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.581
Nazione #
US - Stati Uniti d'America 2.601
GB - Regno Unito 543
CN - Cina 360
SE - Svezia 310
IT - Italia 270
VN - Vietnam 258
DE - Germania 250
IN - India 140
UA - Ucraina 108
IE - Irlanda 92
RU - Federazione Russa 74
FR - Francia 72
SG - Singapore 64
CH - Svizzera 53
ZA - Sudafrica 48
TG - Togo 47
EE - Estonia 38
CI - Costa d'Avorio 35
BG - Bulgaria 26
NG - Nigeria 24
JO - Giordania 21
BE - Belgio 19
IR - Iran 19
FI - Finlandia 17
CA - Canada 12
NL - Olanda 6
TR - Turchia 6
GR - Grecia 5
LB - Libano 5
AU - Australia 4
BR - Brasile 4
HR - Croazia 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
AM - Armenia 2
HU - Ungheria 2
JP - Giappone 2
LU - Lussemburgo 2
PK - Pakistan 2
PL - Polonia 2
PT - Portogallo 2
SC - Seychelles 2
TW - Taiwan 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 5.581
Città #
Southend 501
Fairfield 341
Chandler 278
Ashburn 196
Wilmington 176
Woodbridge 173
Houston 170
Dong Ket 154
Seattle 148
Princeton 135
Ann Arbor 131
Cambridge 130
Dublin 92
Bologna 71
Nanjing 62
Westminster 53
Padova 51
Bern 50
Singapore 50
New York 49
Lomé 47
Beijing 41
Jacksonville 39
Abidjan 35
Bremen 35
Hyderabad 35
Berlin 31
Jinan 29
Saint Petersburg 29
Nanchang 28
Shenyang 26
Sofia 26
Abeokuta 24
Hebei 23
Amman 21
Brussels 19
Tianjin 19
Jiaxing 18
Medford 18
Falls Church 17
Mülheim 17
San Diego 17
Helsinki 15
Changsha 13
Milan 13
Boardman 12
Taizhou 12
San Venanzo 11
Haikou 10
Ningbo 10
Redmond 10
Toronto 10
Turin 10
Hangzhou 9
Redwood City 9
Guangzhou 8
Zhengzhou 8
Olalla 7
Ardabil 6
Bühl 6
Leawood 6
Los Angeles 6
Monmouth Junction 6
Rome 6
Boydton 5
Florence 5
Lanzhou 5
London 5
Norwalk 5
San Francisco 5
Taiyuan 5
Trabia 5
Zanjan 5
Dearborn 4
Des Moines 4
Frankfurt Am Main 4
Fuzhou 4
Istanbul 4
Kuban 4
Pune 4
Ravenna 4
San Mateo 4
Acton 3
Cesena 3
Den Haag 3
Edinburgh 3
Fremont 3
Kunming 3
Melbourne 3
Pesaro 3
Phoenix 3
Agrate Conturbia 2
Andover 2
Bari 2
Budapest 2
Busseto 2
Deiva Marina 2
Frankfurt am Main 2
Hong Kong 2
Kampala 2
Totale 3.934
Nome #
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 178
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 175
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 148
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 146
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 143
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 140
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 134
IFI16 expression is related to selected transcription factors during B-cell differentiation 133
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 132
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 128
BCL10 down-regulation in peripheral T-cell lymphomas. 128
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 126
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 125
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 125
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 122
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 121
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 120
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 119
Pathobiology of hodgkin lymphoma. 119
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 117
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 116
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 113
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 110
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 104
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 103
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. 101
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 99
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. 99
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 99
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 98
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 98
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 97
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. 94
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 89
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. 89
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 89
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 84
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 83
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 82
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 80
Intracellular TCR-signaling Pathway: Novel Markers for Lymphoma Diagnosis and Potential Therapeutic Targets 80
Tissue micro-array in haematopathology:present usage and potential. 79
P27 regulation in peripheral T-cell lymphoma not otherwise specified 79
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive 79
Gene expression profiling of peripheral T-cell lymphoma: From bench to bedside 77
Detection of LMO2 in Normal Human Tissue and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody. 73
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 70
null 68
Expression of classical NF-kappa B pathway molecules in peripheral t-cell lymphoma not otherwise specified. 67
Proliferation centres in chronic lymphocytic leucemia: correlation with cytogenetic and clinicobiological features in 183 patients analyzed on tissue-microarrays. 65
Peripheral T-cell lymphoma. A still uncurable disease? 63
PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. 57
LMO2 is a useful marker for the study and diagnosis of haematolymphoid neoplasms. 56
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified 50
Three-dimensional models: a novel approach for lymphoma research 32
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 28
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation 23
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial 21
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 21
TOX Expression in Mycosis Fungoides and Sezary Syndrome 16
Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence 15
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease 15
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 14
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection 13
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model 7
Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes 4
Correction to: Three-dimensional models: a novel approach for lymphoma research 4
Totale 5.782
Categoria #
all - tutte 14.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.290 0 35 16 99 140 137 181 183 188 105 76 130
2020/2021788 149 54 32 26 10 27 8 34 100 26 34 288
2021/20221.137 106 65 62 68 103 56 21 62 35 143 237 179
2022/20231.313 161 181 72 153 104 96 31 64 233 27 105 86
2023/2024427 21 67 39 35 35 99 26 25 17 40 12 11
2024/2025102 102 0 0 0 0 0 0 0 0 0 0 0
Totale 5.782